A poll has been sent to Industry Members' emails to schedule the first Industry Liaison Committee Meeting in the coming weeks.
#ISCT2021 Breaking News – ISCT and WHO launch CGT nomenclature standards at ISCT 2021!
Find out more: https://mailchi.mp/isctglobal/te-rmplenary-6252360
We shall be updating Participants of the iPSC Quality Assessment Round on the manuscript shortly. A professional statistician re-analysed the amalgamated dataset to fortify the paper.
GAiT is also planning its first Industry Liaisons committee meeting. Internal discussions with GAiT Director / CCRM President & CEO Michael May, to discuss schedule, materials, and format, will take place this week. GAiT will then reach out to Industry members directly.
We appreciate Participants' patience - internal reviewers of the paper were dealing with the COVID-19 response, delaying matters. As agreed, we will allow a final review before submission.
Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation @NeemaMayor @spellman_s, @AnthonyNolan, @CIBMTR @sophpacz
Confirming the impact of ultra-high resolution #HLA typing
Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation
PURPOSE Ultrahigh resolution (UHR) HLA matching is reported to result in better outcomes following unrelated donor hem...
We are getting ready to welcome you to #EFI2021
All registered delegates should have received their conference log-in details & virtual delegate bag yesterday afternoon, if you didn’t receive this email contact email@example.com
@BSHI_transplant @EFI_Office @BSHIconference
Attention #ISSCR trainee members! Register before the early registration deadline (23:59 EDT on 21 April), and add the pre-meeting Workshop on Clinical Translation to your cart at no cost. #ISSCR2021 http://ow.ly/tWG650EtfvB @CatalentPharma
GAiT has been reorganizing for the next stage in its growth and development. More ambitious goals necessitated internal reviews, strategic decisions, and system restructuring. Thankfully our operations are now again normalized and we shall now be more communicative with members.
"I think we're ready - I would even say we're waiting," @EMA_News Exec Director Emer Cooke told me when I asked her if the agency is ready for the coming wave of ATMPs. Looking forward to sharing the full #CGMED21 keynote address with attendees next week! https://meetingonthemed.com/
Longtime #ISSCR member and President of the Korean Society for Stem Cell Research (KSSCR), Jiwhan Song shares the focus of his research, what led him to become a scientist, and what he does in his free time! #MemberMonday #MemberSpotlight http://ow.ly/cU2t50E3uKI
#ISCT2021 program now available!
Find session descriptions at
6 Plenaries • 6 Tracks • 48+ Sessions
ISCT 2021 Program
Session descriptions now available!
Thanks to Maxime Feyeux @TreefrogTx for interviewing GAiT about its efforts to clarify the roadmap for iPSC translation. The interview will appear as a Podcast in the 'In The Stem Cell Jungle' series shortly.
In the Stem Cell Jungle I Webcast by Maxime Feyeux
The idea of having laid-back conversations with academic and industry leaders in the field of stem cells and cell ...
Happy International Women's Day. Half of GAiT's Directors are women: Jacqueline Barry (CGTCatapult), Susan Solomon (NYSCF) and Annelise Bennaceur Griscelli (INSERM).
To avail of an extra three months of GAiT industry membership at no extra cost, remember to pay your annual industry subscription this week.
Pluripotent Stem Cell Manufacturing Expert Panels - developing action plans to deal with common challenges http://gait.global/expert-panels-2019-agenda/ We look forward to the follow up meeting later this year.
Industry membership subscriptions are now due. Pay before 10th March and extend your company's membership an extra three months at no extra cost.
Pluripotent Stem Cell Manufacturing Expert Panels - developing action plans to deal with common challenges http://www.gait.global/expert-panels-2019-agenda/ We look forward to the follow up meeting later this year.
Before COVID-19, we built a network of QC experts, transplantation experts, developers, manufacturers, registry managers, regulatory affairs experts & other stakeholders to map out an efficient roadmap for iPSC therapeutics. We now work online but the work continues.
Pluripotent Stem Cell Manufacturing Expert Panels - organised by GAiT, @CIRMnews, @ISCT, ISCBI and HESI. Developing action plans to deal with common challenges. We look forward to a follow up meeting later this year. http://www.gait.global/expert-panels-2019-agenda/